URAT1&XO inhibitor 2

Modify Date: 2024-01-24 16:22:55

URAT1&XO inhibitor 2 Structure
URAT1&XO inhibitor 2 structure
Common Name URAT1&XO inhibitor 2
CAS Number 1239488-96-0 Molecular Weight 322.15
Density N/A Boiling Point N/A
Molecular Formula C14H12BrNO3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of URAT1&XO inhibitor 2


URAT1&XO inhibitor 2 (Compound BDEO) is a dual inhibitor of xanthine oxidase and URAT1, with IC50 of 3.3 μM for xanthine oxidase. URAT1&XO inhibitor 2 blocks uptake of uric acid in HEK293 cells expressing URAT1, with a Ki value of 0.145 μM. URAT1&XO inhibitor 2 decreases serum urate level and uric acid excretion in hyperuricemic mice. URAT1&XO inhibitor 2 can be used for research of hyperuricemia[1].

 Names

Name URAT1&XO inhibitor 2

 URAT1&XO inhibitor 2 Biological Activity

Description URAT1&XO inhibitor 2 (Compound BDEO) is a dual inhibitor of xanthine oxidase and URAT1, with IC50 of 3.3 μM for xanthine oxidase. URAT1&XO inhibitor 2 blocks uptake of uric acid in HEK293 cells expressing URAT1, with a Ki value of 0.145 μM. URAT1&XO inhibitor 2 decreases serum urate level and uric acid excretion in hyperuricemic mice. URAT1&XO inhibitor 2 can be used for research of hyperuricemia[1].
Related Catalog
References

[1]. Hu Q, et al. (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1. Biomed Pharmacother. 2017 Feb;86:88-94.  

 Chemical & Physical Properties

Molecular Formula C14H12BrNO3
Molecular Weight 322.15
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.